Glyn Edwards appointed as chief executive of Summit

pharmafile | April 4, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Glyn Edwards, summit 

Summit, a UK drug discovery company, has appointed Glyn Edwards as its new chief executive.

Edwards will take up the position with immediate effect and will also join the company’s board of directors. 

He is also the interim chief executive of the BioIndustry Association, but is expected to step down from this role in the near future.

He has a wealth of expertise garnered from a thirty-year career in the life sciences industry, during which time he has held a number of senior executive and business development roles. 

Advertisement

He also has proven commercial track record of successfully partnering drug programmes with major pharma companies, having completed a number of licensing deals. 

Edwards said: “I am pleased to be joining Summit at what I believe is an exciting stage in its development. 

“The Company has a number of promising drug programmes and an innovative technology platform, and I look forward to working with the team to uncover the potential of these assets.”

Related Content

No items found
The Gateway to Local Adoption Series

Latest content